STAAR Surgical Management
Management criteria checks 1/4
STAAR Surgical's CEO is Tom Frinzi, appointed in Jan 2023, has a tenure of 1.83 years. total yearly compensation is $10.22M, comprised of 7.7% salary and 92.3% bonuses, including company stock and options. directly owns 0.046% of the company’s shares, worth €578.53K. The average tenure of the management team and the board of directors is 1.8 years and 3.1 years respectively.
Key information
Tom Frinzi
Chief executive officer
US$10.2m
Total compensation
| CEO salary percentage | 7.7% |
| CEO tenure | 1.8yrs |
| CEO ownership | 0.05% |
| Management average tenure | 1.8yrs |
| Board average tenure | 3.1yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 27 2024 | n/a | n/a | US$22m |
| Jun 28 2024 | n/a | n/a | US$17m |
| Mar 29 2024 | n/a | n/a | US$15m |
| Dec 29 2023 | US$10m | US$788k | US$21m |
| Sep 29 2023 | n/a | n/a | US$20m |
| Jun 30 2023 | n/a | n/a | US$26m |
| Mar 31 2023 | n/a | n/a | US$33m |
| Dec 30 2022 | US$274k | n/a | US$40m |
| Sep 30 2022 | n/a | n/a | US$38m |
| Jul 01 2022 | n/a | n/a | US$34m |
| Apr 01 2022 | n/a | n/a | US$29m |
| Dec 31 2021 | US$250k | n/a | US$28m |
| Oct 01 2021 | n/a | n/a | US$23m |
| Jul 02 2021 | n/a | n/a | US$21m |
| Apr 02 2021 | n/a | n/a | US$11m |
| Jan 01 2021 | US$182k | n/a | US$6m |
Compensation vs Market: Tom's total compensation ($USD10.22M) is above average for companies of similar size in the German market ($USD1.64M).
Compensation vs Earnings: Tom's compensation has increased by more than 20% in the past year.
CEO
Tom Frinzi (68 yo)
1.8yrs
Tenure
US$10,220,581
Compensation
Mr. Thomas G. Frinzi, also known as Tom, serves as Executive Chairman of the Board at ViaLase, Inc. since November 2022 and joined the company in November 2022. He serves as Executive Chair at Aurion Biote...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 1.8yrs | US$10.22m | 0.046% € 578.5k | |
| Chief Financial Officer | 4.3yrs | US$2.82m | 0.070% € 871.3k | |
| Chief Operating Officer | 1.6yrs | US$3.42m | 0.0089% € 110.8k | |
| Chief Technology Officer | 7.7yrs | US$2.41m | 0.036% € 451.8k | |
| Chief Medical Officer | 7.1yrs | US$2.48m | 0.064% € 796.7k | |
| Vice President of Investor Relations & Corporate Development | no data | no data | no data | |
| General Counsel & Corporate Secretary | less than a year | no data | no data | |
| Chief Marketing Officer | less than a year | no data | no data | |
| Senior Vice President of Commercial Operations - North America & APAC | 8yrs | US$2.54m | 0.060% € 753.8k | |
| Chief Clinical | 1.6yrs | no data | 0.0061% € 76.5k | |
| Senior Vice President of Operations | no data | no data | 0.066% € 825.7k |
1.8yrs
Average Tenure
60.5yo
Average Age
Experienced Management: SR3's management team is not considered experienced ( 1.8 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 4.4yrs | US$10.22m | 0.046% € 578.5k | |
| Lead Independent Director | 8.8yrs | US$294.87k | 0.031% € 385.3k | |
| Independent Director | 2.4yrs | US$259.96k | 0.031% € 390.3k | |
| Independent Director | less than a year | US$99.69k | 0.0093% € 116.2k | |
| Member of Optometric Advisory Council | 16yrs | no data | no data | |
| Independent Director | less than a year | no data | 0.0085% € 106.9k | |
| Independent Director | less than a year | no data | 0.0072% € 90.0k | |
| Independent Director | 3.8yrs | US$249.99k | 0.010% € 129.6k |
3.1yrs
Average Tenure
55yo
Average Age
Experienced Board: SR3's board of directors are considered experienced (3.1 years average tenure).